SCHEMBL7836281

SCHEMBL7836281

Cc1cn(-c2ccccn2)c(=O)n(CCCCl)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
GAA P10253 4/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.36
ADRB2 P07550 1/20 0.36
STAT6 P42226 1/20 0.36
HTT P42858 1/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRD4 O60885 2/20 0.35
ADORA2A P29274 1/20 0.35
PDCD1 Q15116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7833117 0.82 TNF (0.36) ADORA2A
SCHEMBL7831992 0.81 PRKCA (0.38) GAATSHRKDM4EALDH1A1CYP2C19
SCHEMBL7833035 0.79 ADORA2A (0.37) GAATSHRKDM4EALDH1A1NPSR1
SCHEMBL7832813 0.79 CYP2E1 (0.43) CYP3A4CYP2C19CYP2C9ADORA2A
SCHEMBL7830433 0.78 KDM4E (0.45) GAATSHRMAPK1KDM4EALDH1A1
SCHEMBL7835400 0.74 ALDH1A1 (0.36) SMN1; SMN2GAAPOLBTSHRMAPK1
SCHEMBL7830011 0.74 TSHR (0.34) GAATSHRL3MBTL1ADORA2A
SCHEMBL7834052 0.74 PDE4A (0.40) POLBL3MBTL1BRD4ADORA2A
SCHEMBL7821435 0.74 KDM4E (0.42) KDM4EALDH1A1LMNA
SCHEMBL7832968 0.72 HPGD (0.47) SMN1; SMN2POLBHIF1AL3MBTL1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed